Literature DB >> 8956780

Interphase cytogenetics of prostate cancer: fluorescence in situ hybridisation (FISH) analysis of Japanese cases.

H Matsuura1, T Shiraishi, R Yatani, J Kawamura.   

Abstract

No numerical aberration of chromosomes that might be specific for prostate cancer has so far been established. We used fluorescence in situ hybridisation (FISH) with centromere-specific probes for chromosomes 7, 8, 17, X and Y to establish the distribution of centromere copy numbers in frozen-stored or freshly prepared samples of benign prostate hypertrophy (BPH) and to detect numerical aberrations of these chromosomes in 28 prostate cancers from Japanese men. There was no significant difference in the data of centromere copy numbers between fresh and frozen-stored tissue. The most common aberration in prostate cancers was a gain of chromosome 8 (57%), with numerical aberration of chromosome 7 being the second most frequent anomaly (50%). Numerical aberration of chromosome 7 is most significantly associated with a higher Gleason score (GS) (P < 0.005) or with lymph node metastasis (P < 0.001). Numerical aberration of several chromosomes, including chromosomes 7 and/or 8, was common in aggressive prostate cancers. Loss of chromosome Y was detected in only 4% of cases. FISH analysis thus proved to be a useful method for detecting numerical aberrations of individual chromosomes, with application to touch preparations of frozen-stored tissue having the advantage of exact sampling of cancer foci. The results suggest that numerical aberration of chromosome 7 is associated with aggressive tumour behaviour and poor prognosis of patients with prostate cancer. The association between genetic change and chromosomal abnormality should be studied in detail.

Entities:  

Mesh:

Year:  1996        PMID: 8956780      PMCID: PMC2077208          DOI: 10.1038/bjc.1996.617

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  38 in total

1.  Fluorescence in situ hybridization with DNA probes.

Authors:  B Trask; D Pinkel
Journal:  Methods Cell Biol       Date:  1990       Impact factor: 1.441

2.  Polysomy of chromosome 7 is associated with amplification and overexpression of the EGF-receptor gene in a human carcinoma cell line derived from a brain metastasis.

Authors:  E Helseth; A Brøgger; A Dalen; H Fure; S G Johansen; M E Lier; T Skandsen; G Unsgaard; R Vik
Journal:  APMIS       Date:  1990-11       Impact factor: 3.205

3.  Detection of trisomy 8 in hematological disorders by in situ hybridization.

Authors:  R E Kibbelaar; H van Kamp; E J Dreef; J W Wessels; G C Beverstock; A K Raap; W E Fibbe; G J den Ottolander; P M Kluin
Journal:  Cytogenet Cell Genet       Date:  1991

4.  Centromeric copy number of chromosome 7 is strongly correlated with tumor grade and labeling index in human bladder cancer.

Authors:  F M Waldman; P R Carroll; R Kerschmann; M B Cohen; F G Field; B H Mayall
Journal:  Cancer Res       Date:  1991-07-15       Impact factor: 12.701

5.  Cytogenetics of primary prostatic adenocarcinoma. Clonality and chromosome instability.

Authors:  M A Micale; A Mohamed; W Sakr; I J Powell; S R Wolman
Journal:  Cancer Genet Cytogenet       Date:  1992-07-15

6.  Frequency and pattern of karyotypic abnormalities in human prostate cancer.

Authors:  A R Brothman; D M Peehl; A M Patel; J E McNeal
Journal:  Cancer Res       Date:  1990-06-15       Impact factor: 12.701

7.  Interphase molecular cytogenetic analysis of epithelial ovarian carcinomas.

Authors:  D L Persons; L C Hartmann; J F Herath; T J Borell; W A Cliby; G L Keeney; R B Jenkins
Journal:  Am J Pathol       Date:  1993-03       Impact factor: 4.307

8.  Chromosomal anomalies in atypical adenomatous hyperplasia and carcinoma of the prostate using fluorescence in situ hybridization.

Authors:  J Qian; R B Jenkins; D G Bostwick
Journal:  Urology       Date:  1995-12       Impact factor: 2.649

9.  Detection of chromosome aneuploidy in interphase nuclei from human primary breast tumors using chromosome-specific repetitive DNA probes.

Authors:  P Devilee; R F Thierry; T Kievits; R Kolluri; A H Hopman; H F Willard; P L Pearson; C J Cornelisse
Journal:  Cancer Res       Date:  1988-10-15       Impact factor: 12.701

10.  Cytogenetic survey of 32 cancers of the prostate.

Authors:  S Arps; A Rodewald; B Schmalenberger; P Carl; M Bressel; H Kastendieck
Journal:  Cancer Genet Cytogenet       Date:  1993-04
View more
  1 in total

Review 1.  Molecular pathology of prostate cancer.

Authors:  C Hughes; A Murphy; C Martin; O Sheils; J O'Leary
Journal:  J Clin Pathol       Date:  2005-07       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.